70 related articles for article (PubMed ID: 34356990)
41. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
[TBL] [Abstract][Full Text] [Related]
42. Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era.
Lea D; Håland S; Hagland HR; Søreide K
Scand J Gastroenterol; 2014 Oct; 49(10):1153-63. PubMed ID: 25144865
[TBL] [Abstract][Full Text] [Related]
43. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
44. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.
Couturier-Maillard A; Secher T; Rehman A; Normand S; De Arcangelis A; Haesler R; Huot L; Grandjean T; Bressenot A; Delanoye-Crespin A; Gaillot O; Schreiber S; Lemoine Y; Ryffel B; Hot D; Nùñez G; Chen G; Rosenstiel P; Chamaillard M
J Clin Invest; 2013 Feb; 123(2):700-11. PubMed ID: 23281400
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells.
Wu S; Kanda T; Nakamoto S; Imazeki F; Yokosuka O
Anticancer Res; 2012 Sep; 32(9):3775-83. PubMed ID: 22993319
[TBL] [Abstract][Full Text] [Related]
46. Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.
Guirado M; Gil H; Saenz-Lopez P; Reinboth J; Garrido F; Cozar JM; Ruiz-Cabello F; Carretero R
Hum Immunol; 2012 Jun; 73(6):668-72. PubMed ID: 22504414
[TBL] [Abstract][Full Text] [Related]
47. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.
Morikawa T; Kuchiba A; Liao X; Imamura Y; Yamauchi M; Qian ZR; Nishihara R; Sato K; Meyerhardt JA; Fuchs CS; Ogino S
Int J Cancer; 2012 Sep; 131(5):1169-78. PubMed ID: 22038927
[TBL] [Abstract][Full Text] [Related]
48. Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis.
Stronati L; Negroni A; Pierdomenico M; D'Ottavio C; Tirindelli D; Di Nardo G; Oliva S; Viola F; Cucchiara S
Dig Liver Dis; 2010 Dec; 42(12):848-53. PubMed ID: 20452301
[TBL] [Abstract][Full Text] [Related]
49. PrognoScan: a new database for meta-analysis of the prognostic value of genes.
Mizuno H; Kitada K; Nakai K; Sarai A
BMC Med Genomics; 2009 Apr; 2():18. PubMed ID: 19393097
[TBL] [Abstract][Full Text] [Related]
50. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
Van Cutsem E; Köhne CH; Hitre E; Zaluski J; Chang Chien CR; Makhson A; D'Haens G; Pintér T; Lim R; Bodoky G; Roh JK; Folprecht G; Ruff P; Stroh C; Tejpar S; Schlichting M; Nippgen J; Rougier P
N Engl J Med; 2009 Apr; 360(14):1408-17. PubMed ID: 19339720
[TBL] [Abstract][Full Text] [Related]
51. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
Anticancer Res; 2008; 28(6B):3865-70. PubMed ID: 19192642
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori and gastric cancer: the causal relationship.
Peter S; Beglinger C
Digestion; 2007; 75(1):25-35. PubMed ID: 17429205
[TBL] [Abstract][Full Text] [Related]
53. Nuclear factor-kappaB in cancer development and progression.
Karin M
Nature; 2006 May; 441(7092):431-6. PubMed ID: 16724054
[TBL] [Abstract][Full Text] [Related]
54. Cancer: inflammation by remote control.
Mantovani A
Nature; 2005 Jun; 435(7043):752-3. PubMed ID: 15944689
[No Abstract] [Full Text] [Related]
55. Colorectal cancer.
Weitz J; Koch M; Debus J; Höhler T; Galle PR; Büchler MW
Lancet; 2005 Jan 8-14; 365(9454):153-65. PubMed ID: 15639298
[TBL] [Abstract][Full Text] [Related]
56. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
57. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
[TBL] [Abstract][Full Text] [Related]
58. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses.
Chin AI; Dempsey PW; Bruhn K; Miller JF; Xu Y; Cheng G
Nature; 2002 Mar; 416(6877):190-4. PubMed ID: 11894097
[TBL] [Abstract][Full Text] [Related]
59. At the crossroads of inflammation and tumorigenesis.
Cordon-Cardo C; Prives C
J Exp Med; 1999 Nov; 190(10):1367-70. PubMed ID: 10562311
[No Abstract] [Full Text] [Related]
60. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer.
Jaafar RF; Ibrahim Z; Ataya K; Hassanieh J; Ard N; Faraj W
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356990
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
